Boston-based Dana-Farber Cancer Institute, Columbus-based Ohio State University Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute, and the Inflammatory Breast Cancer Research Foundation have launched a joint research initiative on metastatic inflammatory breast cancer.
The initiative will unite the Dana-Farber and OSU-James comprehensive inflammatory breast cancer clinics, according to a July 17 news release from Dana-Farber.
The organizations will study quality-of-life outcomes, including lymphedema and treatment-decision regret, and evaluate local therapy approaches such as mastectomy and regional radiation.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.